Bangkok Hospital Phuket in Collaboration with Prince of Songkla University: Pioneering a Globally Patented CAR-T Cell Therapy
Phuket, Thailand – In a historic milestone for medical innovation, Bangkok-Phuket Cancer Institute by Bangkok Hospital Phuket have signed a landmark Memorandum of Understanding (MOU) with the Faculty of Medicine, Prince of Songkla University (PSU). This partnership is set to transform Thailand into a premier global destination for advanced cancer care.
Phuket, Thailand – In a historic milestone for medical innovation, Bangkok-Phuket Cancer Institute by Bangkok Hospital Phuket have signed a landmark Memorandum of Understanding (MOU) with the Faculty of Medicine, Prince of Songkla University (PSU). This partnership is set to transform Thailand into a premier global destination for advanced cancer care.
The collaboration focuses on the joint development and clinical integration of the PSU CD-19 CAR-T Cell Therapy, a cutting-edge cancer treatment that genetically reprograms a patient's own white blood cells into highly effective "cancer killers."
Pioneering Milestones in Thai Healthcare
This partnership introduces several groundbreaking "firsts" for both the region and the global medical community:
A Globally Patented Innovation: The "PSU CD-19 CAR-T Cell" is a proudly Thai-developed medical breakthrough and holds a unique patent globally. By producing this advanced therapy locally, the collaboration significantly reduces the cost of treatment compared to imported alternatives, making world-class immunotherapy far more accessible.
First Private Hospital in Thailand for Adult Care: Bangkok-Phuket Cancer Institute by Bangkok Hospital Phuket is now the first private hospital in Thailand to offer this highly specialized CAR-T cell therapy for adult patients, setting a new standard for private healthcare.
Targeting Complex Diseases: The therapy is specifically designed to combat relapsed or refractory cases of Lymphoma, Leukemia, and Systemic Lupus Erythematosus (SLE). Clinical results for PSU CD-19 CAR-T have demonstrated a staggering cure rate of nearly 90% in late-stage patients who have not responded to other treatments.
Transforming Phuket into a Global Medical Hub
Beyond academic collaboration, this MOU signals a strategic push to elevate Thailand’s position on the world stage. By integrating PSU’s globally patented medical technology with Bangkok-Phuket Cancer Institute by Bangkok Hospital Phuket’s world-class healthcare infrastructure, the alliance aims to serve patients from across the globe.
With plans currently underway by PSU to build an international-standard manufacturing facility capable of treating over 100 patients annually, Phuket is poised to become a vital sanctuary for international medical travelers seeking cutting-edge, life-saving cancer therapies in a world-renowned healing environment.
Source :
Articles in this category are written by our editorial team to keep you informed about the latest healthcare and medical tourism news.
